Topics
News
CME/CE
Editorial Advisory Board
Partnerships
Tazarotene indications may soon expand
Los Angeles - Already approved for the treatment of acne, tazarotene (Tazorac) is being investigated for the treatment of facial photodamage and clogged pores. The FDA is expected to grant regulatory approval for tazarotene to treat photodamaged facial skin within a few months.
Related Videos
Related Content
